Heart Transplant Survivor Secures Anti-Rejection Drug After Insurance Issues
A heart transplant recipient, Payton Herres, faced a challenge accessing a vital anti-rejection medication, everolimus, after her insurer reportedly stopped coverage and costs increased.
Reported by Times of India
AN
2 min read
Language


